Autonomix Medical, Inc. (NASDAQ:AMIX) Financings
Financings
| Raise | Date |
|---|---|
| Common stock issued on exercise of July 2026 warrants, with new unregistered Series E-1 and E-2 warrants Announced: about US$4.9M · US$5.75 a share · Warrants at US$6.25 for 60 months · Maxim Group LLC Dealers: Maxim Group LLC (lead) | Aug 25, 2026 |
| Common stock issued on exercise of November 2025 warrants Announced: about US$2.6M · US$6 a share · ½ warrant at US$5.75 for 66 months · Maxim Group LLC Dealers: Maxim Group LLC (lead) | Jul 14, 2026 |
| Private placement of shares of common stock (or pre-funded warrants) and Series C warrants Announced: about US$5M · US$1.1107 a share · ½ warrant at US$0.8607 for 66 months · Maxim Group LLC Dealers: Maxim Group LLC (lead) | Nov 18, 2025 |
| Warrant exercise of shares of common stock upon exercise of existing warrants Announced: about US$2.5M · US$1.723 a share · ½ warrant at US$1.723 for 66 months · Ladenburg Thalmann & Co. Inc. Dealers: Ladenburg Thalmann & Co. Inc. (lead) Use of proceeds: Working capital and general corporate purposes | Jul 22, 2025 |
| Public offering of common stock units and pre-funded warrant units Closed: US$10M raised · US$6.54 a unit · 1 warrant at US$6.54 for 60 months · Ladenburg Thalmann & Co. Inc. Dealers: Ladenburg Thalmann & Co. Inc. (lead) Use of proceeds: Fund its clinical trial, other research and development, development of intellectual property, and working capital | Nov 25, 2024 |